Abbott Laboratories (ABT) Current Assets (2009 - 2026)

Abbott Laboratories (ABT) has 18 years of Current Assets data on file, last reported at $25.5 billion in Q1 2026.

• For the quarter ending Q1 2026, Current Assets rose 10.17% year-over-year to $25.5 billion; the trailing twelve-month figure through Mar 2026 stood at $25.5 billion (up 10.17% YoY), and the FY2025 full-year result was $26.0 billion, up 9.89% from the prior year.
• Current Assets fell to $25.5 billion in Q1 2026, from $26.0 billion in the prior quarter.
• In the past five years, Current Assets ranged from a high of $26.0 billion in Q4 2025 to a low of $22.4 billion in Q1 2024.
• A 5-year average of $24.0 billion and a median of $23.8 billion in 2024 frame the typical range for Current Assets.
• Across the five-year window, Current Assets climbed 10.29% in 2022 and fell 10.13% in 2023, its largest moves.
• Tracing ABT's Current Assets over 5 years: stood at $25.2 billion in 2022, then slipped by 10.13% to $22.7 billion in 2023, then advanced by 4.35% to $23.7 billion in 2024, then grew by 9.89% to $26.0 billion in 2025, then declined by 1.88% to $25.5 billion in 2026.
• Business Quant data shows ABT's Current Assets at $25.5 billion in Q1 2026, $26.0 billion in Q4 2025, and $24.8 billion in Q3 2025.